As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

Cancer researchers have chased the idea of a universal cancer vaccine for decades. The promise sounds bold and almost ...

From the chairperson of the Abuse in Care Royal Commission of Inquiry to a champion racing driver, a look at who is being ...

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered that SARS-CoV-2, the virus that causes ...

A preliminary study found that people receiving immunotherapy for lung cancer or melanoma lived longer if they had received ...

Dengue is one of the world's fastest-spreading mosquito-borne diseases, causing millions of infections annually. Half of the ...

Three new dames and four knights have been announced in this year's New Year Honours - and the capital is home to three of ...

When asked about pancreatic cancer, physicians roll out a grim parade of statistics. Only around one in ten people survive for more than five years after diagnosis. Average survival is just four ...